134 related articles for article (PubMed ID: 8289063)
1. Zaragozic acids D and D2: potent inhibitors of squalene synthase and of Ras farnesyl-protein transferase.
Dufresne C; Wilson KE; Singh SB; Zink DL; Bergstrom JD; Rew D; Polishook JD; Meinz M; Huang L; Silverman KC
J Nat Prod; 1993 Nov; 56(11):1923-9. PubMed ID: 8289063
[TBL] [Abstract][Full Text] [Related]
2. Zaragozic acids: a family of fungal metabolites that are picomolar competitive inhibitors of squalene synthase.
Bergstrom JD; Kurtz MM; Rew DJ; Amend AM; Karkas JD; Bostedor RG; Bansal VS; Dufresne C; VanMiddlesworth FL; Hensens OD
Proc Natl Acad Sci U S A; 1993 Jan; 90(1):80-4. PubMed ID: 8419946
[TBL] [Abstract][Full Text] [Related]
3. Inhibitory activity to protein prenylation and antifungal activity of zaragozic acid D3, a potent inhibitor of squalene synthase produced by the fungus, Mollisia sp. SANK 10294.
Tanimoto T; Ohya S; Tsujita Y
J Antibiot (Tokyo); 1998 Apr; 51(4):428-31. PubMed ID: 9630865
[TBL] [Abstract][Full Text] [Related]
4. Competitive inhibition of squalene synthetase by squalestatin 1.
Hasumi K; Tachikawa K; Sakai K; Murakawa S; Yoshikawa N; Kumazawa S; Endo A
J Antibiot (Tokyo); 1993 Apr; 46(4):689-91. PubMed ID: 8501015
[No Abstract] [Full Text] [Related]
5. The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. I. Taxonomy, fermentation, isolation, physico-chemical properties and biological activity.
Dawson MJ; Farthing JE; Marshall PS; Middleton RF; O'Neill MJ; Shuttleworth A; Stylli C; Tait RM; Taylor PM; Wildman HG
J Antibiot (Tokyo); 1992 May; 45(5):639-47. PubMed ID: 1624366
[TBL] [Abstract][Full Text] [Related]
6. Discovery, biosynthesis, and mechanism of action of the zaragozic acids: potent inhibitors of squalene synthase.
Bergstrom JD; Dufresne C; Bills GF; Nallin-Omstead M; Byrne K
Annu Rev Microbiol; 1995; 49():607-39. PubMed ID: 8561474
[TBL] [Abstract][Full Text] [Related]
7. The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. II. Structure elucidation.
Sidebottom PJ; Highcock RM; Lane SJ; Procopiou PA; Watson NS
J Antibiot (Tokyo); 1992 May; 45(5):648-58. PubMed ID: 1624367
[TBL] [Abstract][Full Text] [Related]
8. The preparation of zaragozic acid A analogues by directed biosynthesis.
Chen TS; Petuch B; MacConnell J; White R; Dezeny G; Arison B; Bergstrom JD; Colwell L; Huang L; Monaghan RL
J Antibiot (Tokyo); 1994 Nov; 47(11):1290-4. PubMed ID: 8002393
[TBL] [Abstract][Full Text] [Related]
9. Production of additional squalestatin analogues by directed biosynthesis.
Cannell RJ; Dawson MJ; Hale RS; Hall RM; Noble D; Lynn S; Taylor NL
J Antibiot (Tokyo); 1994 Feb; 47(2):247-9. PubMed ID: 8150722
[No Abstract] [Full Text] [Related]
10. Effect of squalene synthase inhibition on the expression of hepatic cholesterol biosynthetic enzymes, LDL receptor, and cholesterol 7 alpha hydroxylase.
Ness GC; Zhao Z; Keller RK
Arch Biochem Biophys; 1994 Jun; 311(2):277-85. PubMed ID: 7911291
[TBL] [Abstract][Full Text] [Related]
11. Massive production of farnesol-derived dicarboxylic acids in mice treated with the squalene synthase inhibitor zaragozic acid A.
Vaidya S; Bostedor R; Kurtz MM; Bergstrom JD; Bansal VS
Arch Biochem Biophys; 1998 Jul; 355(1):84-92. PubMed ID: 9647670
[TBL] [Abstract][Full Text] [Related]
12. Selective inhibition of farnesyl-protein transferase blocks ras processing in vivo.
Gibbs JB; Pompliano DL; Mosser SD; Rands E; Lingham RB; Singh SB; Scolnick EM; Kohl NE; Oliff A
J Biol Chem; 1993 Apr; 268(11):7617-20. PubMed ID: 8463291
[TBL] [Abstract][Full Text] [Related]
13. Protein farnesyltransferase: measurement of enzymatic activity in 96-well format using TopCount microplate scintillation counting technology.
Harwood HJ
Anal Biochem; 1995 Apr; 226(2):268-78. PubMed ID: 7793628
[TBL] [Abstract][Full Text] [Related]
14. Biological activities of novel zaragozic acids, the potent inhibitors of squalene synthase, produced by the fungus, Mollisia sp. SANK 10294.
Tanimoto T; Hamano K; Onodera K; Hosoya T; Kakusaka M; Hirayama T; Shimada Y; Koga T; Tsujita Y
J Antibiot (Tokyo); 1997 May; 50(5):390-4. PubMed ID: 9207908
[TBL] [Abstract][Full Text] [Related]
15. CP-225,917 and CP-263,114, novel Ras farnesylation inhibitors from an unidentified fungus. I. Taxonomy, fermentation, isolation, and biochemical properties.
Dabrah TT; Harwood HJ; Huang LH; Jankovich ND; Kaneko T; Li JC; Lindsey S; Moshier PM; Subashi TA; Therrien M; Watts PC
J Antibiot (Tokyo); 1997 Jan; 50(1):1-7. PubMed ID: 9066758
[TBL] [Abstract][Full Text] [Related]
16. Comparative study of the inhibition of rat and tobacco squalene synthase by squalestatins.
Fulton DC; Tait M; Threlfall DR
Phytochemistry; 1995 Mar; 38(5):1137-41. PubMed ID: 7766395
[TBL] [Abstract][Full Text] [Related]
17. Selective protection and relative importance of the carboxylic acid groups of zaragozic acid A for squalene synthase inhibition.
Biftu T; Acton JJ; Berger GD; Bergstrom JD; Dufresne C; Kurtz MM; Marquis RW; Parsons WH; Rew DR; Wilson KE
J Med Chem; 1994 Feb; 37(3):421-4. PubMed ID: 8308869
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationships of C1 and C6 side chains of zaragozic acid A derivatives.
Ponpipom MM; Girotra NN; Bugianesi RL; Roberts CD; Berger GD; Burk RM; Marquis RW; Parsons WH; Bartizal KF; Bergstom JD
J Med Chem; 1994 Nov; 37(23):4031-51. PubMed ID: 7966163
[TBL] [Abstract][Full Text] [Related]
19. Farnesol-derived dicarboxylic acids in the urine of animals treated with zaragozic acid A or with farnesol.
Bostedor RG; Karkas JD; Arison BH; Bansal VS; Vaidya S; Germershausen JI; Kurtz MM; Bergstrom JD
J Biol Chem; 1997 Apr; 272(14):9197-203. PubMed ID: 9083051
[TBL] [Abstract][Full Text] [Related]
20. Total synthesis of the squalene synthase inhibitor zaragozic acid C by a carbonyl ylide cycloaddition strategy.
Nakamura S; Hirata Y; Kurosaki T; Anada M; Kataoka O; Kitagaki S; Hashimoto S
Angew Chem Int Ed Engl; 2003 Nov; 42(43):5351-5. PubMed ID: 14613174
[No Abstract] [Full Text] [Related]
[Next] [New Search]
